Carcinoma Transitional Cell
📧 Sign up to get email alerts when something new happens for Carcinoma Transitional Cell.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-29EMA Authorised: Padcev (Enfortumab vedotin) — Astellas Pharma Europe B.V.
EMA authorizes Padcev (enfortumab vedotin) for specified urologic carcinoma indications, marking an official market approval.
-
EMA approval · 2026-07-22EMA Authorised: Padcev (Enfortumab vedotin) — Astellas Pharma Europe B.V.
The EMA authorised Padcev (enfortumab vedotin) for indicated urologic cancers, marking a new approval by Astellas Pharma Europe B.V.
-
EMA approval · 2026-06-25EMA Authorised: Padcev (Enfortumab vedotin) — Astellas Pharma Europe B.V.
EMA authorised Padcev (enfortumab vedotin) for conditions within transitional cell carcinoma and urologic neoplasms.
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract [Phase 2]
A phase 2 trial comparing nab-paclitaxel plus S-1 versus gemcitabine plus cisplatin as first-line therapy for locally advanced or metastatic…
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study [Phase 3]
Phase 3 trial update for the OLYMPUS study evaluating optimized delivery of mitomycin for upper tract urothelial carcinoma has completed wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer [Phase 2]
Phase 2 trial evaluating oxaliplatin and gemcitabine in metastatic bladder cancer (carcinoma, transitional cell); study terminated with resu…
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer [Phase 1]
Phase 1 trial evaluating enzalutamide with gemcitabine and cisplatin in bladder cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-04-04Clinical Trial Update: Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial Cancer [Phase 2]
Phase 2 trial evaluating vinflunine as maintenance therapy in metastatic urothelial carcinoma has completed.